NewsBenzingaBarclays mantiene il giudizio “Overweight” su Repligen, alza il target di prezzo a 225 dollari. Barclays mantiene il giudizio “Overweight” su Repligen, alza il target di prezzo a 225 dollari. Benzinga 2026.10.07 15:20 (GMT+0) Open on Benzinga Other news Truist Securities Maintains Buy on Viking Therapeutics, Lowers Price Target to $85 The Stock Market Is Falling: VIX Says Investors Aren’t Really Scared Yet Truist Securities Maintains Buy on United Parcel Service, Lowers Price Target to $115 Truist Securities Maintains Hold on Stryker, Lowers Price Target to $310 Truist Securities Maintains Buy on SM Energy, Raises Price Target to $48 Air Products and Chemicals To Supply Malaysia's First LNG-Based Air Separation Unit For Petronas Gas Berhad-Led Joint Venture; To Design, Build And Operate LNG-Based ASU in Johor; Facility To Produce Over 600 Tonnes Per Day, Expected Onstream By Early...
Air Products and Chemicals To Supply Malaysia's First LNG-Based Air Separation Unit For Petronas Gas Berhad-Led Joint Venture; To Design, Build And Operate LNG-Based ASU in Johor; Facility To Produce Over 600 Tonnes Per Day, Expected Onstream By Early...
